Intravitreal Bevacizumab in Vitreous Hemorrhage and Diabetes Mellitus

نویسندگان

  • Beuy Joob
  • Viroj Wiwanitkit
  • Cengiz Alagöz
  • Yusuf Yıldırım
  • Murat Kocamaz
  • Ökkeş Baz
  • Uğur Çiçek
  • Burcu Çelik
  • Halil İbrahim Demirkale
  • Ahmet Taylan Yazıcı
  • Muhittin Taşkapılı
چکیده

Dear Editor, The recent report on “Intravitreal Bevacizumab in Vitreous Hemorrhage and DM” is very interesting.1 Alagöz et al.1 noted that “intravitreal bevacizumab was found effective in cases with vitreous hemorrhage secondary to proliferative diabetic retinopathy in terms of reducing the need for surgery and increasing the rate of subjects to whom panretinal photocoagulation could be applied in the early period, although there was no impact on final visual acuity”.1 There is no doubt that intravitreal bevacizumab can be a good alternative management. However, there are many concerns. First, the cost of intravitreal bevacizumab is high and it is an issue for further assessment of cost effectiveness. Second, although there is no serious complication due to intravitreal bevacizumab administration, subconjunctival hemorrhage is common and becomes an issue for consideration in diabetes mellitus cases.2,3 Also, in cases with underlying severe diabetes mellitus, possible unwanted gastrointestinal side effects have been reported.4 Onoda et al.4 suggested that “ophthalmologists should apply alternative therapies instead of intravitreal bevacizumab to patients with severe diabetes mellitus”.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Role of bevacizumab in the prevention of early postoperative haemorrhage after 25-gauge microincision vitrectomy surgery

OBJECTIVE To evaluate the effect of preoperative intravitreal bevacizumab injection on the incidence of postoperative haemorrhage and visual prognosis, in patients undergoing 25-gauge micro incision vitrectomy surgery (MIVS) for diabetic vitreous haemorrhage. METHODS One hundred and twenty two eyes of 122 patients of diabetic retinopathy of both genders and aged over 18 years, who presented w...

متن کامل

Aggressive retinal astrocytoma associated with tuberous sclerosis

We report the case of a patient with an aggressive retinal astrocytoma accompanied with macular edema and neovascular vessels, who was initially treated with intravitreal bevacizumab injections. A 24-year-old male presented to our clinic complaining of visual disturbance in his right eye. At 8 years of age, he had been diagnosed as having tuberous sclerosis complex. Fundus examination demonstra...

متن کامل

Two Cases of Acute Abdomen after an Intravitreal Injection of Bevacizumab

We report on a patient with ischemic colitis and another with paralytic ileus, both of whom experienced an acute abdomen after intravitreal injection of bevacizumab (IVB). Case 1 was a 78-year-old woman. Her medical history included surgery for colon carcinoma 10 years earlier. The patient developed acute severe abdominal pain and nausea the day after IVB for retinal vein occlusion with macular...

متن کامل

Intravitreal bevacizumab treatment for retinal neovascularization and vitreous hemorrhage in proliferative diabetic retinopathy

PURPOSE To report the short term anatomical and visual acuity response after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy. METHODS Ten eyes having proliferative diabetic retinopathy were treated with at least one intravitreal injection of bevacizumab, 1.25 mg in 0.05 mL. Patients underwent complete ophthalmologic evaluation at baseline and follow u...

متن کامل

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects

OBJECTIVES To evaluate the efficacy of intravitreal bevacizumab (IVB) in the resolution of vitreous hemorrhage (VH) secondary to proliferative diabetic retinopathy (PDR). MATERIALS AND METHODS Seventy eyes of 70 patients (43 male, mean age 55.6±12.2 years) diagnosed with VH secondary to PDR were evaluated retrospectively. Demographic characteristics of the patients, baseline and final clinica...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 47  شماره 

صفحات  -

تاریخ انتشار 2017